Is there a yes or no for every peptide?
No. The exact product, intended use and way it is supplied need their own check.
The Food and Drug Administration, or FDA, is the US medicine agency.
US drug law has no distinct category called “peptide therapy,” as of September 2026.
Compounding is the name for making medicine to fit an order. Ask whether the actual product is approved or made under a specific compounding rule.
What about a name used in energy ads?
MOTS-c and BPC-157 are peptide names you may see in an offer. As checked in September 2026, FDA records showed no approved US medicine containing either one.
That answers approval. It does not, by itself, settle every compounding question or tell you what a product will do for you.
Ask for the exact medicine name. If it is made to order, ask the prescriber and pharmacy which compounding rule allows it and why that rule fits your prescription.
Does “registered” mean “approved”?
Neither FDA registration nor a drug-directory entry gives approval or proves lawful sale, as of September 2026.
Registration is being entered in a system. Approval is a different claim. Ask which one the page is actually making.
Does a prescription settle every question?
As of September 2026, supplying prescription medicine requires a valid order from a licensed health professional.
A prescription is only part of the check. For an approved medicine, look up its exact name in the FDA drug records. For a made-to-order medicine, ask the prescriber and pharmacy to explain the rule they rely on. Check the pharmacy’s licence with the state pharmacy board. If those checks leave the offer unclear, wait to pay.